SERPINE1 and COVID-19: It has been reported that PAI-1 levels > 10.2 ng/mL (sensitivity 83%, specificity 83%) and >TAFI 818.05 ng/mL (sensitivity 83.3%, specificity 71.4%) in the plasma of COVID-19 patients predict mortality [445,446].